T Bae, KY Weon, JW Lee, KH Eum, S Kim… - …, 2015 - pubmed.ncbi.nlm.nih.gov
Epithelial ovarian cancer (EOC) commonly acquires resistance to chemotherapy, and this is the major obstacle to the better prognosis. Elucidating the molecular targets altered by …
Restoration of paclitaxel resistance by CDK1 intervention in drug‐resistant ovarian cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
T Bae, KY Weon, JW Lee, KH Eum, S Kim… - …, 2015 - scholarworks.bwise.kr
Epithelial ovarian cancer (EOC) commonly acquires resistance to chemotherapy, and this is the major obstacle to the better prognosis. Elucidating the molecular targets altered by …
T Bae, KY Weon, JW Lee, KH Eum, S Kim… - …, 2015 - europepmc.org
Epithelial ovarian cancer (EOC) commonly acquires resistance to chemotherapy, and this is the major obstacle to the better prognosis. Elucidating the molecular targets altered by …
T Bae, KY Weon, JW Lee, KH Eum, S Kim… - …, 2015 - search.ebscohost.com
Epithelial ovarian cancer (EOC) commonly acquires resistance to chemotherapy, and this is the major obstacle to the better prognosis. Elucidating the molecular targets altered by …
T Bae, KY Weon, JW Lee, KH Eum, S Kim… - …, 2015 - researchgate.net
Epithelial ovarian cancer (EOC) commonly acquires resistance to chemotherapy, and this is the major obstacle to the better prognosis. Elucidating the molecular targets altered by …